FDA warns health center founder over patient safety in supplement study

The FDA has issued a warning to Dayan Goodenowe, founder of the Dr. Goodenowe Restorative Health Center in Moose Jaw, alleging that a clinical trial for his supplement, ProdromeNeuro, jeopardized participant safety. The trial, conducted between 2020 and 2021, lacked necessary FDA documentation, raising concerns about the validity of its data. Goodenowe is currently facing multiple investigations, including scrutiny over claims made about the effectiveness of his products for ALS and other diseases. Despite these challenges, he is expanding his business into China and Japan.

Want More Context? 🔎